These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 3318429)
21. Nabumetone therapy of osteoarthritis. A six-week, placebo-controlled study. Blechman WJ Am J Med; 1987 Oct; 83(4B):70-3. PubMed ID: 3318432 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in the elderly. Morgan GJ; Poland M; DeLapp RE Am J Med; 1993 Aug; 95(2A):19S-27S. PubMed ID: 8356998 [TBL] [Abstract][Full Text] [Related]
23. Efficacy of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis. Lister BJ; Poland M; DeLapp RE Am J Med; 1993 Aug; 95(2A):2S-9S. PubMed ID: 8356999 [TBL] [Abstract][Full Text] [Related]
24. A double-masked comparison of Naprelan and nabumetone in osteoarthritis of the knee. Naprelan Study Group. Fleischmann RM; Flint K; Constantine G; Kolecki B Clin Ther; 1997; 19(4):642-55. PubMed ID: 9377610 [TBL] [Abstract][Full Text] [Related]
25. Comparison of the efficacy and safety of naproxen CR and nabumetone in the treatment of patients with osteoarthritis of the knee. Cha HS; Koh JH; Jeon CH; Lee CK; Kim JS; Koh EM Int J Clin Pharmacol Ther; 2001 Dec; 39(12):539-45. PubMed ID: 11770835 [TBL] [Abstract][Full Text] [Related]
26. Safety experience with nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis. Eversmeyer W; Poland M; DeLapp RE; Jensen CP Am J Med; 1993 Aug; 95(2A):10S-18S. PubMed ID: 8356997 [TBL] [Abstract][Full Text] [Related]
27. Results of a six-month study comparing the safety and efficacy of nabumetone and aspirin in the treatment of osteoarthritis. Mullen BJ Am J Med; 1987 Oct; 83(4B):74-7. PubMed ID: 3318433 [TBL] [Abstract][Full Text] [Related]
28. Effects of nabumetone compared with naproxen on platelet aggregation in patients with rheumatoid arthritis. Knijff-Dutmer EA; Martens A; vd Laar MA Ann Rheum Dis; 1999 Apr; 58(4):257-9. PubMed ID: 10364907 [TBL] [Abstract][Full Text] [Related]
29. [Comparison of the efficacy and safety of nabumetone and diclofenac sodium in the treatment of patients with rheumatoid arthritis]. Zhonghua Yi Xue Za Zhi; 2001 May; 81(9):557-60. PubMed ID: 11809123 [TBL] [Abstract][Full Text] [Related]
30. The long-term U.S. study--a report on outcome and tolerance. Fleischmann R Eur J Rheumatol Inflamm; 1991; 11(3):50-3. PubMed ID: 1365481 [TBL] [Abstract][Full Text] [Related]
31. Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis. Hedner T; Samulesson O; Währborg P; Wadenvik H; Ung KA; Ekbom A Drugs; 2004; 64(20):2315-43; discussion 2344-5. PubMed ID: 15456329 [TBL] [Abstract][Full Text] [Related]
32. Nabumetone: a clinical appraisal. Helfgott SM Semin Arthritis Rheum; 1994 Apr; 23(5):341-6. PubMed ID: 8036523 [TBL] [Abstract][Full Text] [Related]
33. Comparison of the safety and efficacy of nabumetone and aspirin in the treatment of osteoarthritis in adults. Appelrouth DJ; Baim S; Chang RW; Cohen MH; Englund DW; Germain BF; Hartman SS; Jaffer A; Mullen BJ; Smith FE Am J Med; 1987 Oct; 83(4B):78-81. PubMed ID: 3318434 [TBL] [Abstract][Full Text] [Related]
34. Review of the experience with nabumetone in clinical trials outside of the United States. Jenner PN; Johnson ES Am J Med; 1987 Oct; 83(4B):110-4. PubMed ID: 3318421 [TBL] [Abstract][Full Text] [Related]
35. Nabumetone. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases. Friedel HA; Todd PA Drugs; 1988 May; 35(5):504-24. PubMed ID: 3293969 [TBL] [Abstract][Full Text] [Related]
37. An overview of the long-term safety experience of nabumetone. Willkens RF Drugs; 1990; 40 Suppl 5():34-7. PubMed ID: 2081490 [TBL] [Abstract][Full Text] [Related]
38. Double-blind, placebo-controlled comparison of the safety and efficacy of orally administered etodolac and nabumetone in patients with active osteoarthritis of the knee. Schnitzer TJ; Ballard IM; Constantine G; McDonald P Clin Ther; 1995; 17(4):602-12. PubMed ID: 8565024 [TBL] [Abstract][Full Text] [Related]
39. Efficacy and improved safety--a new anti-arthritic agent. Irani M Eur J Rheumatol Inflamm; 1991; 11(3):43-9. PubMed ID: 1365480 [TBL] [Abstract][Full Text] [Related]
40. German drug monitoring studies with nabumetone. Stroehmann I; Fedder M; Zeidler H Drugs; 1990; 40 Suppl 5():38-42. PubMed ID: 2081491 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]